Durable, personalized immunotherapy in HCC requires precisio level of peptide-MHC-TCR interactions. PeptideXme integrates multi-omics discovery, structural immunology, and functional T-cell modulation to convert transient immune activation into durable, precision-guided anti-tumor immunity.
Liver metabolism & HCC Oncology
Epigenetic & Cancer
HCC Clinical Oncology
Cancer Immunotherapy
Structural Immunology
| lina.zhao@med.lu.se | |
| Phone | +46 737768101 |
| Address | Malmö, SE 214 28, Sweden |